RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the South... (mplementary strengths will help us deliv...)

HOME >> MEDICINE >> NEWS

RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US

Date:11/9/2007

mplementary strengths will help us deliver a new level of service to the South East and give our customers the opportunity to purchase innovative new and quality refurbished equipment, with factory trained local support."

About Radiology Oncology Systems, Inc.

Radiology Oncology Systems, Inc. (ROS) was formed in 1997 with the goal of providing radiation oncology and diagnostic imaging facilities around the world with quality, cost-effective solutions for equipment. The rapidly changing technological advances in radiation therapy and diagnostic imaging have fueled the demand for facilities to add or replace equipment. Since its inception, ROS has helped facilities both in the US and abroad to take advantage of the market environment and acquire excellent systems at significant cost savings. For more information, visit http://www.oncologysystems.com

About Acceletronics, Inc.

Acceletronics specializes in the on-site repair, service, refurbishing, remarketing, and installation of linear accelerators and other oncology and medical imaging equipment. Acceletronics is a distributor of high quality, high technology after-market products used to improve the quality of cancer patient care and is the exclusive North American distributor of the TheraView portal imaging system. Founded in 1981, Acceletronics, Inc. is one of the world's largest and leading independent radiotherapy service and equipment organizations. Acceletronics is registered to ISO 9001:2000 quality system standards. For more information, visit http://www.acceletronics.com

About RS&A, Inc.

Headquartered north of Winston-Salem in Rural Hall, North Carolina, RS&A, Inc. (Radiotherapy Simulators and Accelerators) specializes in the on-site service, repair, refurbishing, remarketing, and installation of linear accelerators, simulators, and other oncology and medical
'/>"/>

SOURCE Acceletronics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories

Post Your Comments:

(Date:12/6/2009)... factor, researchers say , , SUNDAY, Dec. 6 (HealthDay ... the main tumor to other parts of the body ... which may prove a promising target for new drugs ... Previous studies have shown that TGFb (transforming growth factor ... new study, a team from Cancer Research UK used ...

(Date:12/6/2009)... -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... Phase 2b 003-A1 study, known as the 003 ... pre-treated relapsed and refractory multiple myeloma patients. These ... Symposium at the 51st annual meeting of the ... Enrollment in this trial is complete (n=269), and ...

(Date:12/6/2009)... 6, 2009 A new study provides welcome news ... venous thromboembolism (VTE). , The condition is estimated ... and occurs when an abnormal clot forms in a ... and swelling. In some cases, the clot may detach ... heart to the lungs, causing a potentially fatal condition ...

(Date:12/6/2009)... & Fox, LLP says dangerous substances such as asbestos have been ... ... New York, NY (PRWEB) December 6, 2009 -- As parents shop ... to reports of recalls due to lead paint or asbestos contamination, ... children visit hospital emergency rooms each year due to toy-related injuries,” ...

(Date:12/5/2009)... Cuts for a Cause ,, Why: ... other terminal illnesses affecting children. All proceeds from each hair ... Hospital. Guests will enjoy complimentary beverages and hors d,oeuvres, provided ... Falls Church for all guests. Hoa Lai, a DJ known ...

Breaking Medicine News(10 mins):Health News:Breast Cancer's Spread Now Better Understood 2 Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2 Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3 Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4 Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5 Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2 Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2 Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3

[1] Breast Cancer's Spread Now Better Understood [1] Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability [0] New drug shows promise for those with clotting disorders: McMaster researcher [0] Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season [0] Salon Leau to Host 'Cuts for a Cause' to Raise Funds and Spread the Word About Childhood Terminal Illnesses

... on the surface of cancer cells are keys to ... treating and stopping the spread of certain types of ... lung, among others. Armed with a new two-year ... an Illinois-based philanthropic foundation, immunologist Alessandra Franco, M.D., Ph.D., ...

... , , THURSDAY, Jan. 8 (HealthDay News) -- Many people ... new Canadian study says. , Sixty-three percent of study ... for an experiment with a white person rather than a ... about the black person when he left the room. ...

... CHICAGO, Jan. 8 Allscripts-Misys Healthcare,Solutions, Inc., formerly ... announced its financial results for the three and ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b ) , ... three and six months ended November 30, 2008,include ...

... educational Web site offers expert perspectives, advice and ... from the Agency for Healthcare Research and Quality,s ... a federally sponsored network of more than a ... Health Advisory Information Network ( CHAIN ) ...

... HSKA ) announces the following Webcast: , What: ... Year-End 2008 Earnings Conference Call on the Web, ... Where: www.heska.com (click on the Q4 and Year-End 2008 Earnings, ... the front page of this website)., How: Live ...

... StrikesNEW YORK, Jan. 8 United Jewish Communities (UJC) ... to raise $10 million to address humanitarian and social ... to support and stand in solidarity with Israelis during ... control of the Gaza Strip. The funds will enhance ...

Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot'Many Turn Blind Eye to Racism Allscripts Reports Fiscal 2009 Second Quarter Results AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel

(Date:12/4/2009)... MARLTON, N.J., Dec. 4 Thermographic Diagnostic Imaging ... in Marlton, New Jersey continues to provide superior ... thyroid, dental, TMJ and sinus regions to assist ... these areas. ,, Thermography utilizes infrared imaging ...

(Date:12/4/2009)... ,, PHILADELPHIA, Dec. 4 Teamster members employed ... are hard at work educating the public about the ... put Philadelphia,s blood supply at risk. More than ... picket line yesterday when their issues were ignored by ...

(Date:12/4/2009)... Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ... investor teleconference and webcast. Principal investigators will discuss ... multiple myeloma, as featured at the 51st American Society ... begin at 9:00 a.m. CT/10:00 a.m. ET on Monday, ...

[0] Discover Health Through Awareness [0] Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions [0] Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference

... N.J., May 7 Johnson & Johnson,will provide ... May 9,at 4:00 p.m. (Eastern Time) to coincide ... Tampa, Fla. Phase 3 clinical data presentations on,investigational ... analgesic, will be presented for the first time ...

... Individualized Treatment for ... Schizophrenia, ... VNDA ) investigational drug candidate,iloperidone, included its 4-week, short-term Phase ... trials, studying the efficacy,and safety of iloperidone. Iloperidone is a 5HT2/D2 ...

Other Medicine Technology:Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 2 Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 3 Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 4 Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 5 Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 6 Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 7

Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Society's Annual Meeting Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

PINP Phospholipid Antibody, IgM Phospholipid Antibodies Philadelphia Chromosome

RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the South...(mplementary strengths will help us deliv...),Health